A wrist-based optical blood-pressure monitor has the potential to replace cuff monitoring systems for ambulatory blood pressure, suggests a study in the journal Blood Pressure Monitoring. A press release from Aktiia, the Swiss-based company manufacturing the device, states that the novel system uses the same sensors to measure heart rate as those used in wearable devices.
In the study, Cyril Pellaton (Hopital Neuchâtelois de Pourtalès, Neuchâtel, Switzerland) and colleagues enrolled 30 critical patient scheduled to undergo radial arterial catheterisation at an intensive care unit. After inclusion, the team compared “ground-truth” blood pressure measurements at the radial artery simultaneously with optical signals acquired at the contralateral wrist by a prototype of the Aktiia wearable device.
For systolic blood pressure, there was a mean difference (±SD) of 0.0±7.1mmHg between the arterial catheter and the optical device values, with 95% limits of agreement in the Bland-Altman method of -11.9 mmHg to +12.2mmHg (correlation r=0.87, p<0.001). For diastolic blood pressure, a mean difference of 0.0±2.9mmHg between arterial catheter and the optical device values was found, with 95% limits of agreement in the Bland-Altman method of -4.8mmHg to +5.5mmHg (r=0.98, p<0.001).
The press release says the results provide “clear and compelling evidence” on the reliability and accuracy of the optical blood pressure monitoring technology compared to currently accepted methods of blood pressure measurement. It adds that this represents “a major milestone in the clinical activities of company, contributing toward the company’s mission to bring easy, painless blood pressure monitoring to daily life”.
Duc Tin Clinic
Tin tức liên quan
Performance diagnostique de l’interféron gamma dans l’identification de l’origine tuberculeuse des pleurésies exsudatives
A Mixed Phenotype of Airway Wall Thickening and Emphysema Is Associated with Dyspnea and Hospitalization for Chronic Obstructive Pulmonary Disease.
Radiological Approach to Asthma and COPD-The Role of Computed Tomography.
Significant annual cost savings found with UrgoStart in UK and Germany
Thrombolex announces 510(k) clearance of Bashir catheter systems for thromboembolic disorders
Phone: (028) 3981 2678
Mobile: 0903 839 878 - 0909 384 389